FdaApplication
NDA 207947
Identifiers
- fda_app_no: NDA207947
Properties
| Property | Value |
|---|---|
| applicant_name | ACTELION PHARMACEUTICALS US INC |
| application_type | NDA |
| approval_date | 2015-12-21 |
Products (10)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UPTRAVI | SELEXIPAG | 0.2MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 0.15MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 0.8MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 0.1MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 1MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 0.4MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 1.2MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 1.4MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 1.6MG | TABLET;ORAL |
| UPTRAVI | SELEXIPAG | 0.6MG | TABLET;ORAL |
10 products